A recent study demonstrated that some HCC subgroups exhibit cyclin activation through various mechanisms, including HBV and adeno-associated virus type 2 (AAV2) insertions and enhancer hijacking and recurrent CCNA2 fusions, defining a homogenous entity of aggressive HCC [67]. Here, CCNA2 is linked to hepatocellular carcinoma.